BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3469931)

  • 1. Cross-reactivity between human and feline Ia antigens, using a monoclonal antibody HLA-D.m1.
    Kuramochi T; Takeishi M; Ishida T; Kato K; Ishida M
    Am J Vet Res; 1987 Feb; 48(2):186-8. PubMed ID: 3469931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen-presenting capabilities of human monocytes correlates with their expression of HLA-DS, an Ia determinant distinct from HLA-DR.
    Gonwa TA; Picker LJ; Raff HV; Goyert SM; Silver J; Stobo JD
    J Immunol; 1983 Feb; 130(2):706-11. PubMed ID: 6184401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Ia-like antigens (Analysis of the tissue distribution and immunochemical profile with monoclonal antibodies).
    Natali PG; Russo C; Apollonj C; Pellegrino MA; Ferrone S
    Ric Clin Lab; 1981; 11(4):287-300. PubMed ID: 7034133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A reevaluation of the putative association between the Fc gamma receptor and histocompatibility antigens on human mononuclear leukocytes.
    Pulleyblank BM; Falk JA; Letarte M; Dorrington KJ; Falk RE
    J Immunol; 1982 Jun; 128(6):2810-5. PubMed ID: 6210736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [ICO-1 monoclonal antibodies against the constant region of Ia-like (Dr) antigens].
    Baryshnikov AIu; Blokhina NG; Kadagidze ZG; Novikov VV; Trofimova MN
    Eksp Onkol; 1984; 6(4):44-6. PubMed ID: 6389089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of proliferation and NK activity in human lymphocytes by mature myelomonocytic cells: evidence for an HLA-DR-independent MLR stimulatory ability of terminally differentiated nonlymphoid leukemic cell lines and of normal peripheral blood granulocytes.
    Santoli D; Francis MK; Matera L; Ferrero D
    J Immunol; 1983 Aug; 131(2):736-42. PubMed ID: 6306106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of Tac antigen on activated human T cells by anti-Tac monoclonal antibody.
    Tsudo M; Uchiyama T; Takatsuki K; Uchino H; Yodoi J
    J Immunol; 1982 Aug; 129(2):592-5. PubMed ID: 6979578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sharing of Ia antigens between species. IV. Interspecies cross-reactivity of monoclonal antibodies directed against polymorphic mouse Ia determinants.
    Lunney JK; Osborne BA; Sharrow SO; Devaux C; Pierres M; Sachs DH
    J Immunol; 1983 Jun; 130(6):2786-93. PubMed ID: 6406596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of structural properties and cellular distribution of avian Ia antigen by using monoclonal antibody to monomorphic determinants.
    Ewert DL; Munchus MS; Chen CL; Cooper MD
    J Immunol; 1984 May; 132(5):2524-30. PubMed ID: 6201548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in the discovery and definition of monoclonal antibodies for use in feline research.
    Meister RK; Taglinger K; Haverson K; Strohminger N; Mathes LE
    Vet Immunol Immunopathol; 2007 Sep; 119(1-2):38-46. PubMed ID: 17675164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ia antigen on peripheral blood mononuclear leukocytes in man. II. Functional studies of HLA-DR-positive T cells activated in mixed lymphocyte reactions.
    Engleman EG; Benike CJ; Charron DJ
    J Exp Med; 1980 Aug; 152(2 Pt 2):114s-126s. PubMed ID: 6447741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ia antigen on peripheral blood mononuclear leukocytes in man. I. Expression, biosynthesis, and function of HLA-DR antigen non-T cells.
    Engleman EG; Charron DJ; Benike CJ; Stewart GJ
    J Exp Med; 1980 Aug; 152(2 Pt 2):99s-113s. PubMed ID: 6967944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ia antigens on alloreactive T cells in man detected by monoclonal antibodies. Evidence for synthesis of HLA-D/DR molecules of the responder type.
    Charron DJ; Engelman EG; Benike CJ; McDevitt HO
    J Exp Med; 1980 Aug; 152(2 Pt 2):127s-136s. PubMed ID: 6967933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of antigenic determinants on human myeloid colony forming cells with monoclonal antibodies.
    Greenberg P; Grossman M; Charron D; Levy R
    Exp Hematol; 1981 Aug; 9(7):781-7. PubMed ID: 6172283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a monoclonal antibody identifying a CD45RA antigen on feline leukocytes.
    Gengozian N; Foster JS; Kestler DP
    Vet Immunol Immunopathol; 2005 Dec; 108(3-4):253-64. PubMed ID: 16040129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-reactions between mouse Ia and human HLA-D/DR antigens analyzed with monoclonal alloantibodies.
    Pierres M; Rebouah JP; Kourilsky FM; Dosseto M; Mercier P; Mawas C; Malissen B
    J Immunol; 1981 Jun; 126(6):2424-9. PubMed ID: 6785353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DQ1 + DQ3-specific monoclonal antibody cross-reacts with a rat MHC-encoded polymorphic determinant.
    Otová B; Stefanová I; Horejsí V; Nĕmec M; Kren V; Viklický V
    Folia Biol (Praha); 1987; 33(6):424-9. PubMed ID: 3481338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies specific for Ia glycoproteins raised by immunization with activated T cells: possible role of T cellbound Ia antigens as targets of immunoregulatory T cells.
    Janeway CA; Conrad PJ; Lerner EA; Babich J; Wettstein P; Murphy DB
    J Immunol; 1984 Feb; 132(2):662-7. PubMed ID: 6228596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of normal and transformed lymphocyte subsets of nonhuman primates with monoclonal antibodies to human lymphocytes.
    Neubauer RH; Briggs CJ; Noer KB; Rabin H
    J Immunol; 1983 Mar; 130(3):1323-9. PubMed ID: 6296233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the alloactivated E+Ia+ cell capable of stimulating in mixed lymphocyte culture.
    Shen HH; Irigoyen O; Friedman SM; Chess L
    J Immunol; 1982 Jan; 128(1):501-5. PubMed ID: 6459379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.